Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

February 29, 2004

Study Completion Date

May 31, 2007

Conditions
Parkinson DiseaseParkinsonian Syndrome
Interventions
DRUG

levodopa

DRUG

Mirapex (pramipexole)

PROCEDURE

[123I]ß-CIT and SPECT imaging

Trial Locations (13)

12205

Parkinson's Disease and Movement Disorders Center of Albany Medical College, Albany

19107

University of Pennsylvania, Philadelphia

27705

Duke University, Durham

32610

University of Florida Movement Disorders Center, Gainesville

38163

University of Tennessee Health Science Center, Memphis

60611

Northwestern University, Chicago

60612

RUSH University Medical Center, Chicago

80113

Colorado Neurology, PC, Englewood

93030

Pacific Neuroscience Medical Group, Oxnard

06510

Institute for Neurodegenerative Disorders, New Haven

02118

Boston University Medical Center, Boston

01805

Lahey Clinic Medical Center, Burlington

02886

NeuroHealth, Inc., Warwick

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Boehringer Ingelheim

INDUSTRY

collaborator

United States Department of Defense

FED

lead

Institute for Neurodegenerative Disorders

OTHER